Pharmacokinetics and tolerability of modafinil tablets in Chinese subjects
Xu P, Li HD, Zhang BK, Xiao YW, Yuan HY, Zhu YG.
Clinical Pharmacy & Pharmacology Research Institute,
the Second Xiangya Hospital of Central South University,
Changsha, Hunan Province, China.
J Clin Pharm Ther. 2008 Aug;33(4):429-37.


OBJECTIVE: To investigate the pharmacokinetics and tolerability of modafinil in Chinese subjects. METHODS: Twelve healthy volunteers were given an escalating single dose of modafinil (100, 200 and 400 mg) in a three-period study (study 1). Another 12 volunteers received 100 mg twice daily for 7 days in multiple-dose study (study 2). Blood samples were taken from 0 to 60 h for study 1. And samples for study 2 were collected before administration on three consecutive morning and then from 0 to 60 h after the last dose. Pharmacokinetic parameters were calculated and compared with results from published data. RESULTS: In study 1, C(max) and area under the concentration-time curve of modafinil and modafinil acid were increased proportionally with dose levels; t(1/2) was independent on the dose levels. In study 2, the steady state was reached on day 4, and mean trough plasma concentration of modafinil was 1.36 +/- 0.34 mug/mL. Apparent plasma clearance and apparent volume of distribution were lower in 100 mg twice-daily group than those in 100 mg single group. The adverse events were mild and moderate in study 1 and 2. CONCLUSIONS: In this pharmacokinetic study, modafinil was safe and well tolerated by young healthy Chinese subjects. The major pharmacokinetic parameters of modafinil in Chinese subjects are similar to those reported in Caucasians although the half-life seems to be longer in the former than in the latter. This apparent difference requires investigation.

The sleep-switch
Modafinil: structure
Atypical depression
Modafinil and the aviator
Modafinil: pharmacokinetics
Modafinil and the marmoset
Modafinil wakes up sleepy flies
Modafinil versus amphetamine
Modafinil versus methylphenidate
Modafinil v amphetamine v placebo
Fatigue, sleepiness in major depression
Modafinil plus SSRIs for depression and fatigue
Dosing regimen effects of modafinil in narcolepsy
Mood-lifting effect of caloric restriction is mediated by orexin
Modafinil plus selective serotonin reuptake inhibitors (SSRIs)
Modafinil: a dual noradrenergic-dopaminergic mechanism of action?